Gregory Knutson - 25 Apr 2022 Form 4 Insider Report for U.S. Stem Cell, Inc.

Role
Director
Signature
/s/ Gregory Knutson
Issuer symbol
USRM on OTC
Transactions as of
25 Apr 2022
Net transactions value
+$10,000
Form type
4
Filing time
29 Apr 2022, 16:28:21 UTC
Previous filing
25 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction USRM Common Stock Award $10,000 +2,500,000 +9.4% $0.004000 29,175,000 25 Apr 2022 Direct
holding USRM Common Stock 38,005,331 25 Apr 2022 Held by NorthStar Biotech Group, LLC of which Gregory Knutson is Managing Director
* An asterisk sign (*) next to the price indicates that the price is likely invalid.